Redox Control of F. tularensis Pathogenesis
Redox Control of F. tularensis Pathogenesis
批准号:
8711175
负责人:
Edmund J Gosselin
金额:
$42.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAnti-Inflammatory AgentsAnti-inflammatoryAntigen-Antibody ComplexAntigensAntioxidantsAttenuatedBacteriaBacterial InfectionsBacteriologyBiologyBioterrorismC57BL/6 MouseCategoriesCell physiologyCellsCellular biologyDNADevelopmentEnvironmentEnzymesFc ReceptorFrancisella tularensisFree RadicalsGenerationsGoalsGrowthImmuneImmune responseImmune systemImmunityImmunobiologyImmunologyIn VitroIndividualInfectionInflammatoryLeadLinkLipidsLungMediatingMonitorMouse StrainsMusNitrogenOxidation-ReductionOxygenPathogenesisPharmaceutical PreparationsPhasePhosphoric Monoester HydrolasesPhosphotransferasesProductionPropertyProteinsResearch PersonnelResistanceRoleScientistSignal PathwaySignal TransductionSignaling MoleculeSystemTherapeutic InterventionTularemiaVaccine AntigenVaccinesVirulenceVirulentcrosslinkcytokinecytotoxicenzyme activityimmune functionimmunogenicin vivomacrophagemucosal vaccinationmutantpathogenresponsesuccesstoolvaccination strategyvaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Protective immune responses to bacterial infection are triggered by pathogen derived proteins, DNA and lipid
components which trigger a diverse array of activation signals. Upon activation, the host inflammatory cells
respond to the pathogen-derived insult by the production of inflammatory cytokines and the generation of
both reactive oxygen and nitrogen sJDecies (ROS/RNS) that are the cytotoxic effector molecules of the innate
immune response. Many pathogens resist the production of macrophage (M0)-derived ROS/RNS by
augmenting their ability to detoxify these species or by short circuiting the signaling pathways that lead to
their production. A pathogens antioxidant armature not only provides direct protection from oxidative attack,
but may interfere with host cell signaling that facilitates its intracellular survival by restricting both the effector
and inductive mechanisms responsible for protective immunity. These unique features have led us to
develop a hypothesis that links the efficient ROS/RNS scavenging capacity of Francisella tularensis (Ft)
SchuS4 to its ability to restrict M0 activity. The end result is the creation of an intraM0 environment that is
permissive for growth and subsequent systemic dissemination of this category A pathogen. The underiying
hypothesis is that F. tularensis modulates the intracellular redox environment to control M0 signaling
and function. We will: Aim 1. Investigate how Ft antioxidant defenses contribute to its effective growth and
intracellular survival both in vitro and in vivo. Aim 2. Determine the role of Ft SchuS4 antioxidants in
regulating M0 function directly or when targeted via FcR. Aim 3. Determine the redox-sensitive signaling
molecules that are responsible for the control of M0 kinase signaling upon infection with FcR-targeted or
non-targeted Ft.
The studies outlined will not only decipher the redox-triggers that control Ft virulence but also synergize with
the overall P01 by developing tools that enable subprojects 1 & 2 to evaluate the contribution Ft SchuS4
antioxidants in modulating FcR-specific signals, and TLR/NLR engagement, respectively. By identifying the
bacterial redox-factors that mocjulate host immune function we can develop immunogens to optimize
mucosal vaccination platform.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An Adjuvant-Independent Dual-Targeted (Multi-Function) Mucosal Vaccine Platform
-
批准号:8911997
-
项目类别:
-
资助金额:$21.88万
-
财政年份:2015
-
负责人:Edmund J Gosselin
-
依托单位:
Criteria-Directed Vaccine Generation Via Ag Mimicry, Adjuvancy, And APC-Targeting
-
批准号:9300826
-
项目类别:
-
资助金额:$58.4万
-
财政年份:2013
-
负责人:Edmund J Gosselin
-
依托单位:
Criteria-Directed Vaccine Generation Via Ag Mimicry, Adjuvancy, And APC-Targeting
-
批准号:8443445
-
项目类别:
-
资助金额:$58.4万
-
财政年份:2013
-
负责人:Edmund J Gosselin
-
依托单位:
Criteria-Directed Vaccine Generation Via Ag Mimicry, Adjuvancy, And APC-Targeting
-
批准号:8698271
-
项目类别:
-
资助金额:$58.4万
-
财政年份:2013
-
负责人:Edmund J Gosselin
-
依托单位:
Mechanisms Involved in, and Development of, FcR-Enhanced Mucosal Vaccination
-
批准号:8261081
-
项目类别:
-
资助金额:$38.47万
-
财政年份:2009
-
负责人:Edmund J Gosselin
-
依托单位:
Mechanisms Involved in, and Development of, FcR-Enhanced Mucosal Vaccination
-
批准号:7807054
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2009
-
负责人:Edmund J Gosselin
-
依托单位:
Mechanisms Involved in, and Development of, FcR-Enhanced Mucosal Vaccination
-
批准号:7660124
-
项目类别:
-
资助金额:$37.83万
-
财政年份:2009
-
负责人:Edmund J Gosselin
-
依托单位:
Mechanisms Involved in, and Development of, FcR-Enhanced Mucosal Vaccination
-
批准号:8049731
-
项目类别:
-
资助金额:$38.47万
-
财政年份:2009
-
负责人:Edmund J Gosselin
-
依托单位:
Protective Activity of a Multi-Functional Immunogen
-
批准号:7195315
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2007
-
负责人:Edmund J Gosselin
-
依托单位:
Protective Activity of a Multi-Functional Immunogen
-
批准号:7350212
-
项目类别:
-
资助金额:$22.45万
-
财政年份:2007
-
负责人:Edmund J Gosselin
-
依托单位:
ENHANCED T AND B CELL RESPONSES VIA RECOMBINANT PROTEINS
-
批准号:6213323
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2000
-
负责人:Edmund J Gosselin
-
依托单位:
ENHANCED T AND B CELL RESPONSES VIA RECOMBINANT PROTEINS
-
批准号:6374417
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2000
-
负责人:Edmund J Gosselin
-
依托单位:
TWO COMPONENT STRATEGY FOR IMMUNE TARGETING
-
批准号:2642824
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1998
-
负责人:Edmund J Gosselin
-
依托单位:
HUMAN FC RECEPTOR--ENHANCED ANTIGEN PRESENTATION DEFINED
-
批准号:2070930
-
项目类别:
-
资助金额:$10.71万
-
财政年份:1993
-
负责人:Edmund J Gosselin
-
依托单位:
HUMAN FC RECEPTOR--ENHANCED ANTIGEN PRESENTATION DEFINED
-
批准号:3456540
-
项目类别:
-
资助金额:$9.84万
-
财政年份:1993
-
负责人:Edmund J Gosselin
-
依托单位:
HUMAN FC RECEPTOR--ENHANCED ANTIGEN PRESENTATION DEFINED
-
批准号:2070929
-
项目类别:
-
资助金额:$9.82万
-
财政年份:1993
-
负责人:Edmund J Gosselin
-
依托单位:
HUMAN FC RECEPTOR--ENHANCED ANTIGEN PRESENTATION DEFINED
-
批准号:2070931
-
项目类别:
-
资助金额:$11.12万
-
财政年份:1993
-
负责人:Edmund J Gosselin
-
依托单位:
HUMAN FC RECEPTOR--ENHANCED ANTIGEN PRESENTATION DEFINED
-
批准号:2517242
-
项目类别:
-
资助金额:$11.55万
-
财政年份:1993
-
负责人:Edmund J Gosselin
-
依托单位:
Immunology Core
-
批准号:8698578
-
项目类别:
-
资助金额:$23.77万
-
财政年份:--
-
负责人:Edmund J Gosselin
-
依托单位:
Immunology Core
-
批准号:8226349
-
项目类别:
-
资助金额:$34.07万
-
财政年份:--
-
负责人:Edmund J Gosselin
-
依托单位:
海外基金